click on each ESR picture to learn more about his/her background and project
ESR1: Ben He
- Design, synthesis and evaluation of carboxylic acids and bioisosters as potent ERAP/IRAP inhibitors
- Université de Lille - "Drugs and molecules for Living systems" Lab
- Learn more on Ben's project:
ESR2: Vasileios Fougiaxis
- Discovery of potent modulators of ERAP/IRAP by fragment-based drug discovery or Kinetic Target guided synthesis
- Université de Lille - "Drugs and molecules for Living systems" Lab
- Learn more on Vasilis' project:
ESR3: Evgenia-Galateia Georgaki
- Analysis of the structure and mechanism of function of ERAP/IRAP
- Greece - "National Centre for Scientific Research “Demokritos”" Lab
- Learn more on Galateia's project:
ESR4: Martha - Spyridoula Nikopaschou
- Proteomic analysis of ERAP/IRAP role on the immunopeptidome of cancer and immune cells
- Greece - "National Centre for Scientific Research “Demokritos”" Lab
- Learn more on Martha's project:
ESR5: Shami Ãlvarez Mourid
- Effect of Modulation of ERAP1 activity in antigen processing and presentation
- University of Southampton - "Cancer Sciences Unit" Lab
- Learn more on Shami's project:
ESR6: Dario Vinicio Guglietta
- Effect of ERAP1 modulation on induction of protective anti-tumour immunity
- University of Southampton - "Cancer Sciences Unit" Lab
- Learn more on Dario's project:
ESR7: Alice Senni
- Effect of IRAP inhibitors in antigen processing and presenting cell biology
- University of Paris - "Antigen presentation by MHC Dpt" Lab
- Learn more on Alice's project:
ESR8: Nadia Keelan
- Exploring the role of the ERAP and IRAP aminopeptidases in models of T cell-mediated autoimmunity
- University of Paris - "Antigen presentation by MHC Dpt" Lab
- Learn more on Nadia's project:
ESR9: Paula Gragera Alvarez
- ERAP modulation as an innovative strategy for cancer treatment
- Ospedale Pediatrico Bambino Gesù. Roma, IT. - "Onco-haematology" Lab
- Learn more on Paula's project:
ESR10: Kamila Król
- In vivo anti-tumour safety and efficacy of NK cell-based immunotherapeutic approach in preclinical models
- Ospedale Pediatrico Bambino Gesù. Roma, IT. - "Onco-haematology" Lab
- Learn more on Kamila's project:
ESR11: Sandra Llamas Rizo
- Design, synthesis and evaluation of phosphinic transition-state analogues of ERAP/IRAP
- National and Kapodistrian University of Athens, GR - "Organic Chemistry" Lab
- Learn more on Sandra's project:
ESR12: Aroosha Raja
- Molecular ecosystem of ERAP four distinct immune cell subsets from patients with ERAP-linked diseases
- University Medical Center Utrecht, NL - "BoerKuiper group"
- Learn more on Aroosha's project:
ESR13: Adele Ponzoni
- Biomarkers discovery, compounds distribution, efficacy and toxicity analysis by Mass Spectrometry Imaging
- Aliri Bioanalysis
- Learn more on Adele's project:
ESR14: Filipa da Silva de Vasconcelos
- Development of drug delivery systems for ERAP/IRAP modulators
- Inocure & National and Kapodistrian University of Athens, GR - "Polymer" Lab
- Learn more on Filipa's project:
ESR15: Nikoletta Maria Koutroumpa
- Cheminformatics Analysis: Ligand & Structure Based
- NovaMechanics Ltd (CY)
- Learn more on Nikki's project: